pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jul 2·1 min read
save

Presidential fitness test returns as a modest push for youth activity, experts caution limits

Jul 2, 2026·read at STAT ↗Neutral

The health secretary reintroduced a presidential fitness test as part of a campaign to boost youth health and address rising sedentary habits.

Experts say the test is a positive step but not a complete solution; measuring fitness alone does not create lasting activity.

They warn that mandatory testing could embarrass children and potentially turn them away from exercise if not paired with engaging programs.

The consensus is that the test should be combined with broader strategies that make physical activity fun and sustainable for kids.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “The new presidential fitness test is a positive step, not the solution, experts say”

read at STAT ↗
1,048 words · retrieved Jul 2
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
RISING2ELI LILLY COEli Lilly and CoLEADINGLILLYNOVONovo Nordisk Inc
drugs
Obesity2
topics
Cardiology2Obesity2Major Depression

related stories

  • Jul 9Opinion: Who benefits from classifying obesity as a disease?STAT
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Dec 22Fierce Biotech Fundraising Tracker '26: Superluminal snags $60M; AusperBio adds $120MFierce Biotech
  • 16h agoNovartis may cut around 130 in Switzerland while relocating biologics productionBioSpace
  • 6d agoLilly joins Novo in cardiovascular space after FDA nod for GLP-1/GIP agonist MounjaroBioSpace